InvestorsHub Logo
Followers 51
Posts 3935
Boards Moderated 0
Alias Born 03/20/2014

Re: nidan7500 post# 193109

Friday, 05/17/2019 3:25:59 AM

Friday, May 17, 2019 3:25:59 AM

Post# of 458440
This will be seen as over the top and some may be. Time will tell.

It will be a while before people can learn to accept the protocols that establish efficacy in the new trials. The biomarkers, the devices, the durations, interpreting the readouts and data will be changing. Anavex appears to be able to use the actigraph and soon the cognition system to produce a simple straightforward meaningful trial results that don’t require thousands of participants and years of cumbersome recording and analyzing statistical data. Dr. Gottlieb, Harald Hampel and others need to continue mapping out the surest ways to utilize PM in more indications. Gottlieb should be on the Board of the ERP Consortium.

When the first approval comes the date should be noted. Plaques might be installed outside assisted living facilities and maybe a Star on Hollywood Blvd commemorating no more entertainers to be taken by Alzheimer’s. We need to fill some stadiums and have some testimonials. Late night infomercials, Larry King. When polio was cured people were appreciative but without the stream of new victims it didn’t last long. Everyone is going to benefit from this new science. But maybe we should wait for an approval first? Is today too soon?

Figuring out dosing as a prophylactic will be easier with the new technology.

imo
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News